Financial Avengers’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$62.9K Sell
125
-5
-4% -$2.4K 0.03% 56
2026
Q1
$64.1K Sell
130
-21
-14% -$11.4K 0.03% 50
2025
Q4
$87.7K Hold
151
0.04% 47
2025
Q3
$73.3K Hold
151
0.03% 53
2025
Q2
$61.2K Hold
151
0.03% 58
2025
Q1
$75.1K Hold
151
0.04% 50
2024
Q4
$78.4K Hold
151
0.04% 55
2024
Q3
$93.2K Sell
151
-30
-17% -$17.8K 0.05% 50
2024
Q2
$99.8K Buy
181
+1
+0.6% +$573 0.05% 39
2024
Q1
$104K Sell
180
-10
-5% -$5.61K 0.06% 40
2023
Q4
$101K Hold
190
0.06% 42
2023
Q3
$96.2K Buy
+190
New +$101K 0.06% 42

Other funds holding TMO

Financial Avengers's TMO Position: Q2 2026 in Review

Financial Avengers reduced its Thermo Fisher Scientific (TMO) stake by 3.8% in Q2 2026, selling an estimated $2.4K and leaving 125 shares worth $62.9K. The position accounts for 0.03% of the portfolio, ranked #56.

Financial Avengers first reported a position in TMO in Q3 2023 and has held it in 12 quarters since. The position peaked at $104K in Q1 2024. 2,623 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Financial Avengers held 125 shares of Thermo Fisher Scientific worth $62.9K as of Q2 2026.
  • Financial Avengers sold 5 Thermo Fisher Scientific shares in Q2 2026, an estimated $2.4K.
  • Thermo Fisher Scientific made up 0.03% of Financial Avengers's portfolio in Q2 2026, its #56 holding.
  • Financial Avengers first reported a position in Thermo Fisher Scientific in Q3 2023 and has held it in 12 quarters since.
  • Financial Avengers's Thermo Fisher Scientific position peaked at $104K in Q1 2024.
  • 2,623 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Financial Avengers's 13F filing for Q2 2026, filed 19 Aug 2026.